| Value | ₹65.04 Cr |
|---|---|
| Execution period | By end of financial year 31.03.2027 |
NSE filing, NSE: UNIHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Unihealth Hospitals Ltd: key numbers
- Share price
- ₹550.25
- Market cap
- ₹880.4 Cr
- Revenue (annual)
- ₹132.0 Cr
- Net profit (annual)
- ₹25.83 Cr
- P/E (TTM)
- 34.1×Sector 33.4×
- Promoter holding
- 64.82%
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unihealth Hospitals Ltd
All →Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Unihealth Hospitals Business Update
Unihealth Hospitals provided free scoliosis surgeries to two underprivileged children at UMC Hospitals, Navi Mumbai with charitable foundations. No monetary value is stated.
Unihealth Hospitals Other Announcement
Unihealth Hospitals Limited has submitted an intimation regarding the non-applicability of the Corporate Governance compliance report due to its listing on the NSE SME platform.
Unihealth Hospitals Convertible Warrants
Unihealth Hospitals allotted 2,00,000 equity shares upon conversion of warrants at Rs. 151 per share, totaling Rs. 3.02 Crore.
- Value
- ₹3.02 Cr
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals has issued a postal ballot notice seeking shareholder approval for a material related party transaction, IPO proceeds variation, and migration to the main board.
- Value
- ₹26.00 Cr
Unihealth Hospitals Annual General Meeting
UniHealth Hospitals Limited issued a Postal Ballot notice seeking shareholder approval for a related party transaction, IPO proceeds variation, and migration to the main board.
Other merger & restructuring announcements
All →Symphony Merger & Restructuring Worth ₹27 Cr
Symphony will sell its Bodakdev vacant land for ₹27 Crore, versus ₹5.68 Crore book value. Sale deed is expected November 6, 2026; operations are unaffected.
- Value
- ₹27.00 Cr
Juniper Green Energy Merger & Restructuring Worth ₹0.15 Cr
Juniper Green Energy incorporated wholly owned subsidiary Juniper Green Beta Fifteen Private Limited on October 30, 2026. The company subscribed to 1,50,000 shares for Rs.0.15 Crore.
- Value
- ₹0.15 Cr
Oricon Enterprises Merger & Restructuring Worth ₹145 Cr
Oricon Enterprises sold its leasehold land and building to Anand Rathi Towers for Rs.145 Crore. The sale is completed and the buyer is unrelated to promoters.
- Value
- ₹145.0 Cr
Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹0 Cr
Sale of 26% stake in subsidiary Clean Max Alps to Bayer Vapi for ₹0.0026 Crore. The subsidiary contributed no revenue or net worth last financial year.
- Value
- ₹0.00 Cr
Vimta Labs Merger & Restructuring Worth ₹0.08 Cr
Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.
- Value
- ₹0.08 Cr
Weagro Merger & Restructuring Worth ₹0.01 Cr
Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.
- Value
- ₹0.01 Cr
- Execution
- Within two months from the date of the Board decision, subject to statutory approvals.